Home/Filings/4/0001209191-24-005677
4//SEC Filing

Whalen Kathleen M 4

Accession 0001209191-24-005677

CIK 0000860730other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:23 PM ET

Size

17.9 KB

Accession

0001209191-24-005677

Insider Transaction Report

Form 4
Period: 2024-05-16
Whalen Kathleen M
SVP & Chief Ethics Officer
Transactions
  • Exercise/Conversion

    Stock Appreciation Right

    2024-05-171,68512,045 total
    Exercise: $133.53Exp: 2028-10-31Common Stock (1,685 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-17$101.16/sh+3,040$307,52612,494 total
  • Sale

    Common Stock

    2024-05-16$326.30/sh3,204$1,045,4659,454 total
  • Exercise/Conversion

    Common Stock

    2024-05-17$133.53/sh+1,685$224,99814,179 total
  • Exercise/Conversion

    Stock Appreciation Right

    2024-05-173,0400 total
    Exercise: $101.16Exp: 2028-01-31Common Stock (3,040 underlying)
  • Tax Payment

    Common Stock

    2024-05-17$322.86/sh2,861$923,70211,318 total
Footnotes (2)
  • [F1]The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
  • [F2]The stock appreciation rights vested in four equal annual installments beginning on October 31, 2019.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001763910

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:23 PM ET
Size
17.9 KB